In vitro and in cellulo interactions of platinum and ruthenium anticancer metallodrugs with RNA
xviii, 125 p. : ill. (some col.) === Since its approval by the FDA in 1978 cisplatin (cis-diamminedichloroplatinum(II)) has revolutionized the treatment of several cancer types, particularly testicular cancer which now has a cure rate greater than 90%. Following the example set by its success, a bro...
| Main Author: | |
|---|---|
| Language: | en_US |
| Published: |
University of Oregon
2011
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1794/11254 |